MEHALICK DAVID enters COEPTIS THERAPEUTICS INC. with 3M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/19/2021ACC: 0001683168-21-000641
DirectorOfficer10% Owner· CEO and President
Since Feb 2021
3M
Baseline shares
100% direct
3M
Direct ownership
1 position
8M
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned3M
Total
3M direct3M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3M | Direct |
| Total | 3M | 3M direct |
Derivative Holdings1
Series B Convertible Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
8M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
8M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Convertible Preferred Stock Direct | Common Stock | — | — | 8M | N/A | |
| Total | 8M | 0.00 | ||||